Covered recipient · General Payments record
MALLORY K RACOSKI
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical
General Payments · PY2021–2024
$3,109.70
- Reported across 183 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $157.04 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $17.91 | 1 |
| GlaxoSmithKline, LLC. | $17.62 | 1 |
| Indivior Inc. | $17.38 | 1 |
| ABBVIE INC. | $16.51 | 1 |
| Biogen, Inc. | $16.16 | 1 |
| Lundbeck LLC | $15.36 | 1 |
| Amgen Inc. | $15.00 | 1 |
| Acerta Pharma LLC | $14.08 | 1 |
| Lilly USA, LLC | $13.68 | 1 |
| Vanda Pharmaceuticals Inc. | $13.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.51 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108052122 | CMS |
| Amgen Inc. | $15.00 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117660977 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.08 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104277487 | CMS |
| Biogen, Inc. | $16.16 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104873158 | CMS |
| GlaxoSmithKline, LLC. | $17.62 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116264764 | CMS |
| Indivior Inc. | $17.38 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144568300 | CMS |
| Lilly USA, LLC | $13.68 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135801812 | CMS |
| Lundbeck LLC | $15.36 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146078764 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.91 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119167418 | CMS |
| Vanda Pharmaceuticals Inc. | $13.34 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133965275 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.